NewEdge Advisors’s Kezar Life Sciences KZR Stock Holding History

NewEdge Advisors’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,176	Closed	-$16.1K	–	4300
2026 Q1	$16.1K	Buy	+2,176	New	+$14.2K	﹤0.01%	3262

NewEdge Advisors's KZR Position: Q2 2026 in Review

NewEdge Advisors sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 2,176 shares — an estimated $16.1K sold.

NewEdge Advisors first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $16.1K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

NewEdge Advisors reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
NewEdge Advisors sold 2,176 Kezar Life Sciences shares in Q2 2026, an estimated $16.1K.
NewEdge Advisors first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
NewEdge Advisors's Kezar Life Sciences position peaked at $16.1K in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.